Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$573K Sell
12,440
-16,918
-58% -$733K 0.08% 388
2017
Q2
$1.3M Buy
29,358
+27,024
+1,158% +$1.14M 0.19% 220
2017
Q1
$96K Buy
+2,334
New +$97.4K 0.02% 544
2016
Q3
Sell
-4,564
Closed -$132K 682
2016
Q2
$132K Sell
4,564
-5,075
-53% -$154K 0.03% 533
2016
Q1
$279K Buy
9,639
+1,947
+25% +$55.8K 0.07% 423
2015
Q4
$249K Sell
7,692
-11,058
-59% -$353K 0.07% 421
2015
Q3
$555K Sell
18,750
-1,687
-8% -$51.7K 0.13% 319
2015
Q2
$630K Buy
20,437
+18,483
+946% +$534K 0.08% 300
2015
Q1
$55K Sell
1,954
-3,313
-63% -$89.9K 0.01% 364
2014
Q4
$143K Buy
+5,267
New +$133K 0.03% 346

Other funds holding SNV

GAM Systematic's SNV Position: Q3 2017 in Review

GAM Systematic reduced its Synovus (SNV) stake by 58% in Q3 2017, selling an estimated $733K and leaving 12,440 shares worth $573K. The position accounts for 0.08% of the portfolio, ranked #388.

GAM Systematic first reported a position in SNV in Q4 2014 and has held it in 10 quarters since. The position peaked at $1.3M in Q2 2017. 294 funds tracked by Wall St. Rank hold SNV as of Q3 2017.

  • GAM Systematic held 12,440 shares of Synovus worth $573K as of Q3 2017.
  • GAM Systematic sold 16,918 Synovus shares in Q3 2017, an estimated $733K.
  • Synovus made up 0.08% of GAM Systematic's portfolio in Q3 2017, its #388 holding.
  • GAM Systematic first reported a position in Synovus in Q4 2014 and has held it in 10 quarters since.
  • GAM Systematic's Synovus position peaked at $1.3M in Q2 2017.
  • 294 funds tracked by Wall St. Rank held Synovus as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.